Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.43 CAD | -0.82% | -0.41% | +120.91% |
Apr. 22 | HC Wainwright Starts Cardiol Therapeutics With Buy Rating, $9 Price Target | MT |
Apr. 01 | Cardiol Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+120.91% | 122M | |
+2.23% | 42.75B | |
+47.70% | 41.61B | |
+11.43% | 41.34B | |
-12.36% | 26.59B | |
+8.63% | 25.49B | |
-23.01% | 18.12B | |
+30.86% | 12.24B | |
-1.44% | 11.76B | |
+8.46% | 11B |
- Stock Market
- Equities
- CRDL Stock
- News Cardiol Therapeutics Inc.
- Canaccord Genuity Adjusts Price Target on Cardiol Therapeutics to $6 From $5, Maintains Buy Rating